Bixalomer

N/A

Report date: 2023/04/13 17:56:00
NME

Base Information

Drug NameBixalomer
Drug Alias Name比沙洛姆KiklinILY-101ASP-1585AMG-223
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPhosphates binders
TargetsPhosphates
Therapy Area/IndicationsHyperphosphatemiaKidney Failure, ChronicRenal Insufficiency, Chronic +[5] 
Global Approved IndicationsHyperphosphatemia
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved Date2012/03/30
Country/TerritoryUnited StatesJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesAmgen Inc
China Registration ClassN/A

Develop Information

Active CompaniesAstellas Pharma Inc
Inactive CompaniesAmgen Research (Munich) GmbhAmgen IncIlypsa Inc
Active IndicationsHyperphosphatemia
Inactive IndicationsKidney Failure, ChronicRenal Insufficiency, ChronicRenal Insufficiency +[4] 

Other Information

ATC CodeB
Related LinksDrugBankKEGG